Soluble wild-type ACE2 molecules inhibit newer SARS-CoV-2 variants and are a potential antiviral strategy to mitigate disease severity in COVID-19

Ameratunga, R; Mears, E; Leung, E; Snell, R; Woon, ST; Kelton, W; Medlicott, N; Jordan, A; Abbott, W; Steele, R; Rolleston, W; Longhurst, H; Lehnert, K

Ameratunga, R (通讯作者)，Auckland Hosp, Adult & Paediat Immunol, Auckland, New Zealand.

CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2023; 214 (3): 289

Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus responsible for coronavirus disease of 2019 (COVID-19), has caused havoc aroun......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索